To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene IFI44LTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
549 supporting clones for gene IFI44L back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_006820.2   .a 1 to 5871 2 to 5872 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 5872/5872
(100 %)
1 diff
(100.0 %id)
DA699730   .a 1 to 521 2 to 522   tiling clone, capped   521/521
(100 %)
2 diff
(99.7 %id)
DA955448 Spleen .a 13 to 454 2 to 443   capped   442/442
(100 %)
1 diff
(99.8 %id)
FN166593 breast carcinoma .a 19 to 98 1 to 78       78/79
(98 %)
6 diff
(92.5 %id)
AL711245 human skeletal muscle .a 27 to 741 1 to 715       715/715
(100 %)
4 diff
(99.5 %id)
DA951623 Spleen .a 29 to 586 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA584101 lung .a 31 to 630 2 to 601   capped   600/600
(100 %)
1 diff
(99.9 %id)
DA485048 brain .a 36 to 607 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
DA952277 Spleen .a 36 to 579 2 to 545   capped   544/544
(100 %)
5 diff
(99.1 %id)
DB199670 trachea .a 36 to 534 2 to 500   capped   499/499
(100 %)
1 diff
(99.8 %id)
DA265140 caudate nucleus .a 41 to 607 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
DA595208 lung .a 41 to 621 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA284981 corpus callosum .a 42 to 594 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DA953512 Spleen .a 42 to 598 2 to 557   capped   556/556
(100 %)
4 diff
(99.3 %id)
DB248821 uterus .a 42 to 603 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DB028281 testis .a 43 to 594 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DA595757 lung .a 44 to 610 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
AK223087   .a 45 to 2112 1 to 2080 H73R V217I R296C AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2080/2080
(100 %)
10 diff
(99.6 %id)
DA593167 lung .a 45 to 597 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DA598916   .a 45 to 603 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
DA600492   .a 45 to 603 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
AU099813   .a 45 to 343 1 to 300       300/300
(100 %)
5 diff
(98.4 %id)
BP272450   .a 45 to 599 1 to 560       560/600
(93 %)
26 diff
(95.7 %id)
DA645570   .a 45 to 614 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA949604 Spleen .a 45 to 611 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA985328 synovial membrane tissue from rheumatioidarthritis .a 45 to 581 2 to 539   capped   538/538
(100 %)
3 diff
(99.5 %id)
DA009271 adrenal gland .a 46 to 608 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA042386 bladder .a 46 to 554 2 to 511   capped   510/510
(100 %)
2 diff
(99.7 %id)
DA044545 bladder .a 46 to 614 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA152238 amygdala .a 46 to 626 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA204445 brain .a 46 to 633 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA671574   .a 46 to 621 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA838944 placenta .a 46 to 591 2 to 547   capped   546/546
(100 %)
4 diff
(99.3 %id)
DA872688 Prostate .a 46 to 622 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA933558 Spleen .a 46 to 607 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA942823 Spleen .a 46 to 616 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA982452 synovial membrane tissue from rheumatioidarthritis .a 46 to 591 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA999810 breast, tumor tissue .a 46 to 600 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DB001022 breast, tumor tissue .a 46 to 588 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DB003866 breast, tumor tissue .a 46 to 580 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DB013219 esophageal, tumor tissue .a 46 to 605 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DB028259 testis .a 46 to 585 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DB110196 thymus .a 46 to 617 2 to 573   capped   572/573
(99 %)
2 diff
(99.7 %id)
DB118446 thymus .a 46 to 585 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DB205489 trachea .a 46 to 629 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DB258001 uterus .a 46 to 618 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA040657 bladder .a 49 to 603 9 to 564   capped   556/556
(100 %)
2 diff
(99.7 %id)
FN058994 breast carcinoma .a 49 to 119 1 to 71       71/71
(100 %)
3 diff
(95.8 %id)
DB002437 breast, tumor tissue .a 49 to 522 8 to 481   capped   474/474
(100 %)
2 diff
(99.6 %id)
BP272526   .a 51 to 653 1 to 603       603/608
(99 %)
15 diff
(97.6 %id)
DA840817 placenta .a 51 to 584 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
DA371016 thalamus .a 53 to 603 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AV657218 corresponding non cancerous liver tissue .a 55 to 446 1 to 393     Submitted on the opposite strand 393/393
(100 %)
2 diff
(99.5 %id)
DA644727   .a 55 to 639 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
BM474034 leiomyosarcoma, uterus .a 57 to 1034 1 to 989       989/997
(99 %)
27 diff
(97.3 %id)
DA043909 bladder .a 58 to 611 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
AB000115 cancellous bone .a 61 to 2112 8 to 2058 K17N L18C G20E N21M V22F ...     2051/2058
(99 %)
9 diff
(99.6 %id)
DA044492 bladder .a 62 to 622 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DN990025 brain, whole brain .a 63 to 590 16 to 543       528/544
(97 %)
10 diff
(98.2 %id)
BP196412 adrenal gland .a 65 to 645 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
AA295288 Pancreas .a 66 to 371 1 to 307       307/307
(100 %)
5 diff
(98.4 %id)
AV757165 bone marrow .a 66 to 719 73 to 721       649/675
(96 %)
15 diff
(97.8 %id)
AA243482 germinal center B cell .a 66 to 554 1 to 488       488/488
(100 %)
2 diff
(99.6 %id)
DA849365 placenta .a 66 to 626 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DB208819 trachea .a 66 to 668 2 to 605   capped   604/608
(99 %)
4 diff
(99.4 %id)
AW959246   .a 67 to 645 1 to 583       583/583
(100 %)
25 diff
(95.8 %id)
DA274210 corpus callosum .a 68 to 625 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
DA644521   .a 68 to 607 2 to 541   capped   540/540
(100 %)
3 diff
(99.5 %id)
DA644881   .a 68 to 644 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
AU122665 mammary gland .a 68 to 880 2 to 818   capped   817/817
(100 %)
14 diff
(98.3 %id)
DA955214 Spleen .a 68 to 638 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA958625 Spleen .a 68 to 621 2 to 556   capped   555/555
(100 %)
3 diff
(99.5 %id)
DB200811 trachea .a 68 to 605 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
AK312272 bladder .a 73 to 1537 1 to 1466 L18X L19A G20W N21K V22C ...     1466/1466
(100 %)
7 diff
(99.6 %id)
BC015932 Uterus, leiomyosarcoma .a 73 to 2112 1 to 2040 exact available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2040/2040
(100 %)
1 diff
(100.0 %id)
DA044130 bladder .a 74 to 577 2 to 506   capped   505/505
(100 %)
2 diff
(99.7 %id)
BP257380 heart .a 77 to 626 1 to 550       550/550
(100 %)
4 diff
(99.3 %id)
DA981532 synovial membrane tissue from rheumatioidarthritis .a 77 to 607 2 to 533   capped   532/532
(100 %)
2 diff
(99.7 %id)
AK225442 heart .a 78 to 1642 1 to 1565 exact tiling clone,   1565/1565
(100 %)
0 diff
(100 %id)
DA384478 thalamus .a 79 to 631 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BE885491 leiomyosarcoma, uterus .a 84 to 706 1 to 621       621/878
(70 %)
10 diff
(98.9 %id)
BE815939 breast_normal .a 87 to 496 11 to 421       411/421
(97 %)
12 diff
(97.2 %id)
BP277706   .a 87 to 668 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BP280654   .a 87 to 670 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP280687   .a 87 to 668 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CB144078 Liver .a 101 to 537 1 to 439       439/439
(100 %)
3 diff
(99.4 %id)
DA382502 thalamus .a 116 to 646 2 to 532   capped   531/532
(99 %)
2 diff
(99.7 %id)
DA377761 thalamus .a 137 to 765 2 to 630   capped   629/629
(100 %)
1 diff
(99.9 %id)
BG213163   .a 167 to 468 20 to 321       302/327
(92 %)
2 diff
(99.4 %id)
AA100692 colon, tumor .a 241 to 604 1 to 367       367/367
(100 %)
19 diff
(94.9 %id)
CV023309 mixed .a 296 to 951 1 to 655       655/655
(100 %)
6 diff
(99.1 %id)
BQ050803 leiomyosarcoma, uterus .a 455 to 1272 1 to 824       824/1054
(78 %)
11 diff
(99.0 %id)
BJ990424 hepatoblastoma .a 492 to 1076 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
FN062498 breast carcinoma .a 527 to 647 121 to 1     Submitted on the opposite strand 121/121
(100 %)
0 diff
(100 %id)
BF750041 breast_normal .a 697 to 1125 17 to 446       430/446
(96 %)
9 diff
(98.0 %id)
AU185269 skin .a 707 to 918 213 to 1       213/213
(100 %)
2 diff
(99.1 %id)
BQ932404 leiomyosarcoma, uterus .a 754 to 1545 1 to 799       797/861
(92 %)
16 diff
(98.2 %id)
DT220636 brain .a 765 to 1397 1 to 633       633/633
(100 %)
0 diff
(100 %id)
BU517170 leiomyosarcoma, uterus .a 805 to 1634 1 to 838       838/853
(98 %)
11 diff
(98.8 %id)
BQ219494 leiomyosarcoma, uterus .a 888 to 1874 11 to 1009       999/1010
(98 %)
32 diff
(96.9 %id)
FN162653 breast carcinoma .a 897 to 980 83 to 1     Submitted on the opposite strand 83/102
(81 %)
1 diff
(99.1 %id)
BU180322 ductal carcinoma, cell line, Pancreas .a 913 to 1769 1 to 866       866/866
(100 %)
17 diff
(98.1 %id)
BM460965 leiomyosarcoma, uterus .a 989 to 1697 13 to 730       718/997
(72 %)
18 diff
(98.2 %id)
H67827 liver and spleen .a 1041 to 1453 1 to 421       421/549
(76 %)
10 diff
(98.2 %id)
EB388879 eye, optic nerve .a 1045 to 1900 1 to 856       856/856
(100 %)
0 diff
(100 %id)
BU856905 adenocarcinoma, cell line, breast .a 1109 to 1982 1 to 880       880/887
(99 %)
8 diff
(99.1 %id)
CK003087 brain/CNS, Human Brain - Cerebellar Cortex .a 1121 to 1805 1 to 676       676/683
(98 %)
15 diff
(97.9 %id)
BM904203 lymph, lymphoma, cell line .a 1135 to 2080 1 to 954   AAA   954/1050
(90 %)
15 diff
(98.6 %id)
BQ187157 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1193 to 1515 1 to 323       323/350
(92 %)
0 diff
(100 %id)
CF618815 Pooled Chondrosarcoma Tumor cells .a 1209 to 1979 9 to 784       776/892
(86 %)
15 diff
(98.4 %id)
CF618814 Pooled Chondrosarcoma Tumor cells .a 1226 to 1812 25 to 616   AAA   592/950
(62 %)
19 diff
(98.0 %id)
FN110503 breast carcinoma .a 1237 to 1336 100 to 1     Submitted on the opposite strand 100/100
(100 %)
0 diff
(100 %id)
BE888406 leiomyosarcoma, uterus .a 1253 to 2020 1 to 760       760/794
(95 %)
36 diff
(95.5 %id)
AW804050 uterus .a 1274 to 1501 228 to 2       227/231
(98 %)
0 diff
(100 %id)
AW804118 uterus .a 1274 to 1492 19 to 237       219/237
(92 %)
7 diff
(97.1 %id)
BE178642 head_neck .a 1274 to 1498 5 to 228       224/232
(96 %)
11 diff
(95.3 %id)
BF378832 uterus .a 1274 to 1498 229 to 6       224/232
(96 %)
0 diff
(100 %id)
AW804044 uterus .a 1294 to 1498 1 to 206       206/210
(98 %)
5 diff
(97.7 %id)
C01751   .a 1305 to 1701 1 to 400       400/409
(97 %)
6 diff
(98.6 %id)
AI688255 colon .a 1328 to 1896 569 to 1       569/569
(100 %)
4 diff
(99.3 %id)
FN137381 breast carcinoma .a 1374 to 1442 1 to 70       70/70
(100 %)
4 diff
(94.3 %id)
FN150830 breast carcinoma .a 1397 to 1476 80 to 1     Submitted on the opposite strand 80/80
(100 %)
0 diff
(100 %id)
FN070530 breast carcinoma .a 1406 to 1494 91 to 1     Submitted on the opposite strand 91/91
(100 %)
2 diff
(97.9 %id)
AI361921 brain, glioblastoma (pooled) .a 1409 to 2112 704 to 1       704/704
(100 %)
6 diff
(99.2 %id)
BU934636 mixed (pool of 40 RNAs) .a 1412 to 2116 1 to 709       709/709
(100 %)
6 diff
(99.2 %id)
BU616973 Cell Line, Chondrosarcoma .a 1416 to 2130 714 to 1   tiling clone,   714/714
(100 %)
2 diff
(99.8 %id)
BE767619 placenta_normal .a 1422 to 1895 478 to 5       474/478
(99 %)
0 diff
(100 %id)
FN166620 breast carcinoma .a 1439 to 1524 85 to 1     Submitted on the opposite strand 85/85
(100 %)
1 diff
(98.9 %id)
CD679111 eye, Trabecular meshwork .a 1446 to 1588 1 to 143       143/143
(100 %)
3 diff
(98.0 %id)
TI_149284709   .a 1477 to 2112 714 to 79   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 636/1086
(58 %)
7 diff
(99.4 %id)
BM984510 lung, Primary Lung Epithelial Cells .a 1492 to 2130 639 to 1       639/639
(100 %)
5 diff
(99.3 %id)
FN170223 breast carcinoma .a 1495 to 1587 94 to 1     Submitted on the opposite strand 94/95
(98 %)
1 diff
(99.0 %id)
CD106974 brain, Pituitary .a 1499 to 2112 1 to 614   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
BU618955 Cell Line, Chondrosarcoma .a 1502 to 2130 630 to 1       630/630
(100 %)
1 diff
(99.9 %id)
CA423461 cell lines, Chondrosarcoma .a 1510 to 2130 621 to 1       621/621
(100 %)
0 diff
(100 %id)
AA410567 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1535 to 1871 1 to 337   fully sequenced,   337/337
(100 %)
1 diff
(99.8 %id)
AU148193 mammary gland .a 1546 to 2112 567 to 1       567/567
(100 %)
20 diff
(96.5 %id)
AA740459 2 pooled tumors (clear cell type), Kidney .a 1565 to 1896 338 to 7       332/339
(97 %)
0 diff
(100 %id)
AA193287 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1579 to 1912 1 to 338   fully sequenced,   338/338
(100 %)
7 diff
(98.0 %id)
AW803050 uterus .a 1588 to 1896 317 to 9       309/317
(97 %)
0 diff
(100 %id)
AI422859 brain, glioblastoma (pooled) .a 1590 to 2112 523 to 1       523/523
(100 %)
0 diff
(100 %id)
BF063199 colon, colon tumor, RER+ .a 1605 to 2113 509 to 1       509/509
(100 %)
1 diff
(99.9 %id)
FN149832 breast carcinoma .a 1657 to 1771 1 to 117       117/117
(100 %)
2 diff
(98.3 %id)
AI051147 brain, glioblastoma (pooled) .a 1658 to 2114 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AI126024 uterus .a 1659 to 2114 456 to 1       456/456
(100 %)
1 diff
(99.8 %id)
AW418659 pooled .a 1659 to 2111 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AI350625   .a 1679 to 2112 438 to 1       438/438
(100 %)
10 diff
(97.8 %id)
AI686888 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1685 to 1928 244 to 1       244/244
(100 %)
0 diff
(100 %id)
AW182219 pooled .a 1687 to 2111 427 to 1       427/427
(100 %)
2 diff
(99.6 %id)
AI951432 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 1691 to 2028 334 to 1       334/334
(100 %)
10 diff
(97.1 %id)
AI342415 lung .a 1692 to 2111 432 to 1       432/432
(100 %)
7 diff
(98.4 %id)
CA429052 Cell Line, Chondrosarcoma .a 1709 to 2295 26 to 613     Submitted on the opposite strand 588/613
(95 %)
6 diff
(99.1 %id)
AI828048 pooled .a 1721 to 2033 313 to 1       313/313
(100 %)
1 diff
(99.7 %id)
BF844126 head_neck .a 1728 to 2038 313 to 1     Submitted on the opposite strand 313/313
(100 %)
15 diff
(95.3 %id)
AI432549 adenocarcinoma, Pancreas .a 1732 to 1928 197 to 1       197/199
(98 %)
0 diff
(100 %id)
AA938694 2 pooled tumors (clear cell type), Kidney .a 1734 to 2118 385 to 1       385/385
(100 %)
0 diff
(100 %id)
AI302476 2 pooled tumors (clear cell type), Kidney .a 1747 to 2112 364 to 1       364/364
(100 %)
2 diff
(99.5 %id)
AW193245 adenocarcinoma, Pancreas .a 1748 to 1928 181 to 1       181/181
(100 %)
0 diff
(100 %id)
AA515349 liposarcoma .a 1757 to 2114 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
FN165405 breast carcinoma .a 1769 to 1871 102 to 1     Submitted on the opposite strand 102/102
(100 %)
1 diff
(99.1 %id)
FN173994 breast carcinoma .a 1769 to 1871 1 to 105       105/105
(100 %)
4 diff
(96.2 %id)
AI282423 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1786 to 1928 143 to 1       143/143
(100 %)
0 diff
(100 %id)
R23461 placenta .a 1793 to 2084 1 to 296   AAA   296/333
(88 %)
10 diff
(97.0 %id)
AI539200 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1795 to 2114 320 to 1       320/320
(100 %)
3 diff
(99.1 %id)
CR745394 liver and spleen .a 1796 to 2454 1 to 658       658/664
(99 %)
3 diff
(99.6 %id)
AA570374 liposarcoma .a 1796 to 2121 333 to 8       326/333
(97 %)
0 diff
(100 %id)
R91240 liver and spleen .a 1797 to 2117 1 to 324       324/324
(100 %)
7 diff
(97.9 %id)
H68098 liver and spleen .a 1797 to 2113 324 to 1       324/324
(100 %)
9 diff
(97.3 %id)
T25739   .a 1816 to 2112 295 to 1       295/296
(99 %)
1 diff
(99.7 %id)
AA410188 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1841 to 2114 274 to 1   fully sequenced,   274/274
(100 %)
0 diff
(100 %id)
AA088869 colon, tumor .a 1845 to 2117 273 to 1       273/273
(100 %)
1 diff
(99.7 %id)
BM955883 tonsil .a 1856 to 2259 1 to 403       403/403
(100 %)
2 diff
(99.6 %id)
AW189617 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1862 to 2116 256 to 1       256/256
(100 %)
2 diff
(99.3 %id)
AV733401 pheochromocytoma .a 1868 to 2150 1 to 278       278/286
(97 %)
8 diff
(97.3 %id)
D29128   .a 1873 to 2112 1 to 246       246/246
(100 %)
8 diff
(96.8 %id)
AA194233 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1882 to 2113 240 to 1   fully sequenced,   240/240
(100 %)
5 diff
(98.0 %id)
AI810827 Prostate .a 1963 to 2527 566 to 2       565/566
(99 %)
0 diff
(100 %id)
N67034.
matches multiple genes
liver and spleen .a 1984 to 2417 435 to 1     also hits gene SLC22A23 435/435
(100 %)
1 diff
(99.8 %id)
AI819264 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2048 to 2521 478 to 1       478/478
(100 %)
31 diff
(93.6 %id)
AI379537 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2052 to 2524 472 to 1       472/472
(100 %)
4 diff
(99.2 %id)
AI347124 adenocarcinoma, colon .a 2083 to 2524 456 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 443/443
(100 %)
2 diff
(99.6 %id)
BX501650 Liver .a 2097 to 2731 1 to 636   tiling clone,   636/636
(100 %)
1 diff
(99.9 %id)
R26059 placenta .a 2103 to 2424 322 to 1       322/331
(97 %)
0 diff
(100 %id)
AA894597 2 pooled tumors (clear cell type), Kidney .a 2128 to 2527 401 to 2       400/401
(99 %)
0 diff
(100 %id)
R91241 liver and spleen .a 2130 to 2418 292 to 4       289/292
(98 %)
0 diff
(100 %id)
AA913818 pooled .a 2178 to 2524 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AA973761 pooled germ cell tumors .a 2180 to 2527 350 to 3       348/350
(99 %)
0 diff
(100 %id)
DA937528 Spleen .a 2182 to 2692 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
FN152626 breast carcinoma .a 2357 to 2472 115 to 5     Submitted on the opposite strand 111/115
(96 %)
0 diff
(100 %id)
BF095308 uterus_tumor .a 2425 to 2849 17 to 443       427/443
(96 %)
6 diff
(98.7 %id)
DB162553 thymus .a 2618 to 3190 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
DA044950 bladder .a 2815 to 3380 2 to 565   tiling clone, capped   564/564
(100 %)
2 diff
(99.7 %id)
NM_006417.4   .b 1 to 1724 1 to 1724 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1724/1724
(100 %)
0 diff
(100 %id)
DN994910 brain, whole brain .b 23 to 716 1 to 693   tiling clone,   693/693
(100 %)
6 diff
(99.2 %id)
BI601280 brain, hypothalamus .b 35 to 791 1 to 756   tiling clone,   756/756
(100 %)
9 diff
(98.9 %id)
DA364812 subthalamic nucleus .b 36 to 604 2 to 571   capped   570/570
(100 %)
7 diff
(98.8 %id)
BX281001 ovary (pool of 3) .b 37 to 574 20 to 555   tiling clone,   536/555
(96 %)
6 diff
(99.0 %id)
BC022870 lung .b 40 to 1720 5 to 1685 W9R available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1681/1681
(100 %)
3 diff
(99.9 %id)
CB127025 cervix, Uterine .b 40 to 715 1 to 676       676/676
(100 %)
3 diff
(99.6 %id)
BP225500   .b 40 to 623 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BG506874 lung .b 40 to 756 1 to 712       690/713
(96 %)
27 diff
(96.3 %id)
DA604887   .b 40 to 550 2 to 513   capped   512/512
(100 %)
3 diff
(99.5 %id)
TI_45210606   .b 40 to 791 112 to 862       751/862
(87 %)
10 diff
(98.9 %id)
DA685504   .b 40 to 609 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BP351520   .b 40 to 619 1 to 580       580/584
(99 %)
4 diff
(99.4 %id)
DC400911 testis .b 40 to 600 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
DB244635 uterus, tumor tissue .b 40 to 597 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB259313 uterus .b 40 to 619 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CB129291 cervix, Uterine .b 41 to 596 1 to 556       556/556
(100 %)
0 diff
(100 %id)
DA581312 lung .b 41 to 601 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BP258409 heart .b 41 to 577 1 to 537       537/565
(95 %)
23 diff
(96.0 %id)
DA611914   .b 41 to 595 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA612275   .b 41 to 605 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA617793   .b 41 to 569 2 to 533   capped   532/532
(100 %)
3 diff
(99.5 %id)
BM761098 lymph node, stomach .b 41 to 741 1 to 701       701/701
(100 %)
0 diff
(100 %id)
BM843739 lymph node, stomach .b 41 to 466 1 to 426       426/426
(100 %)
1 diff
(99.8 %id)
BP351476   .b 41 to 623 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB015843 esophageal, tumor tissue .b 41 to 608 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA129821 alzheimer cortex .b 42 to 594 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA138912 alzheimer cortex .b 42 to 581 2 to 542   capped   541/542
(99 %)
2 diff
(99.7 %id)
DA522149 brain .b 42 to 555 2 to 517   capped   516/516
(100 %)
2 diff
(99.7 %id)
DA604644   .b 42 to 550 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA607999   .b 42 to 623 2 to 585   capped   584/584
(100 %)
4 diff
(99.4 %id)
DA611393   .b 42 to 580 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA670672   .b 42 to 619 2 to 581   capped   580/584
(99 %)
4 diff
(99.4 %id)
DA831679 placenta .b 42 to 817 2 to 783   capped   782/787
(99 %)
14 diff
(98.3 %id)
BM764204 myeloma .b 42 to 570 1 to 529       529/529
(100 %)
0 diff
(100 %id)
DB019200 esophageal, tumor tissue .b 42 to 628 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DB142012 thymus .b 42 to 576 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB190966 lung, tumor tissue .b 42 to 612 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB237307 trachea .b 42 to 623 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DB154460 thymus .b 44 to 636 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
BQ890542 dorsal root ganglia .b 46 to 898 1 to 856       856/865
(98 %)
13 diff
(98.5 %id)
DB214841 trachea .b 46 to 491 10 to 457   capped   448/448
(100 %)
2 diff
(99.6 %id)
DA134376 alzheimer cortex .b 47 to 599 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA681256 ovary .b 47 to 599 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BM547313 ovary (pool of 3) .b 48 to 1131 1 to 1088       1088/1090
(99 %)
38 diff
(96.6 %id)
BQ212068 melanotic melanoma, skin .b 54 to 912 1 to 877       875/930
(94 %)
42 diff
(95.5 %id)
BU167907 leiomyosarcoma, uterus .b 54 to 934 1 to 886       886/891
(99 %)
6 diff
(99.4 %id)
CR621445 placenta .b 57 to 1691 1 to 1635 exact tiling clone,   1635/1635
(100 %)
0 diff
(100 %id)
AL541046 placenta .b 57 to 901 1 to 846   fully sequenced,   846/846
(100 %)
1 diff
(99.9 %id)
CB148135 Liver .b 57 to 595 1 to 541       541/541
(100 %)
4 diff
(99.3 %id)
AL554344 placenta, Placenta Cot 25-normalized .b 70 to 1104 1 to 1034       1034/1034
(100 %)
10 diff
(99.1 %id)
BQ437856 leiomyosarcoma, uterus .b 76 to 935 1 to 860       860/861
(99 %)
3 diff
(99.7 %id)
DA833632 placenta .b 84 to 923 2 to 851   capped   850/853
(99 %)
20 diff
(97.7 %id)
EL735373 mixed .b 125 to 982 1 to 859       859/860
(99 %)
4 diff
(99.6 %id)
TI_1948218785   .b 125 to 824 138 to 837       700/1396
(50 %)
13 diff
(99.1 %id)
TI_1948219023   .b 125 to 738 129 to 745       617/1487
(41 %)
31 diff
(98.0 %id)
TI_1948219024   .b 125 to 969 139 to 985       847/1342
(63 %)
16 diff
(98.9 %id)
TI_1948219275   .b 125 to 824 129 to 828   fully sequenced,   700/828
(84 %)
11 diff
(98.7 %id)
TI_1948219519   .b 125 to 790 128 to 796       669/1392
(48 %)
31 diff
(97.8 %id)
TI_1948219520   .b 125 to 947 128 to 961       834/1391
(59 %)
37 diff
(97.4 %id)
CB267643 adipose .b 133 to 736 1 to 602       602/602
(100 %)
4 diff
(99.4 %id)
CB127379 cervix, Uterine .b 137 to 289 1 to 156       156/156
(100 %)
2 diff
(98.8 %id)
BX492103   .b 145 to 562 1 to 418       418/418
(100 %)
2 diff
(99.6 %id)
BX492121   .b 145 to 622 1 to 478       478/478
(100 %)
0 diff
(100 %id)
BX492122   .b 145 to 567 1 to 423       423/423
(100 %)
11 diff
(97.4 %id)
BP263018 small intestine .b 159 to 743 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
BP366693 thymus .b 252 to 833 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
TI_57163055   .b 307 to 1046 69 to 849       606/849
(71 %)
13 diff
(98.5 %id)
BI049144 uterus .b 339 to 573 11 to 247       237/247
(95 %)
5 diff
(98.0 %id)
BU858699 mixed (pool of 40 RNAs) .b 376 to 824 1 to 449       449/908
(49 %)
11 diff
(98.8 %id)
TI_1948219522   .b 380 to 1458 1204 to 125       1080/1318
(81 %)
46 diff
(96.6 %id)
CB127492 cervix, Uterine .b 387 to 809 1 to 423       423/423
(100 %)
0 diff
(100 %id)
D30842   .b 401 to 786 1 to 385       383/387
(98 %)
6 diff
(98.5 %id)
TI_1948219026   .b 413 to 1458 1167 to 121       1047/1305
(80 %)
31 diff
(97.7 %id)
BF814635 colon_ins .b 417 to 889 475 to 3     Submitted on the opposite strand 473/475
(99 %)
0 diff
(100 %id)
AW957538   .b 499 to 774 24 to 298       275/298
(92 %)
27 diff
(91.0 %id)
BP334838 salivary gland .b 503 to 1068 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
AA353685   .b 507 to 645 17 to 155       139/155
(89 %)
8 diff
(94.9 %id)
BI838416 pooled pancreas and spleen .b 512 to 1046 232 to 780       683/780
(87 %)
38 diff
(95.2 %id)
BF084154 colon .b 587 to 815 238 to 11       228/238
(95 %)
2 diff
(99.2 %id)
AV749706 Pituitary .b 598 to 1032 1 to 430       430/432
(99 %)
13 diff
(97.0 %id)
TI_1948219025   .b 617 to 1458 979 to 123       857/1291
(66 %)
19 diff
(98.6 %id)
TI_1948219521   .b 624 to 1458 978 to 123       856/1323
(64 %)
31 diff
(97.7 %id)
AL577084 placenta, Placenta Cot 25-normalized .b 633 to 1663 1026 to 1       1026/1031
(99 %)
49 diff
(95.3 %id)
BQ379873 uterus_tumor .b 671 to 1010 360 to 22       339/366
(92 %)
8 diff
(97.9 %id)
CR978802 T-Lymphocytes .b 671 to 1443 1 to 772       772/773
(99 %)
4 diff
(99.5 %id)
TI_1948219276   .b 784 to 1458 801 to 124   fully sequenced,   678/801
(84 %)
0 diff
(100 %id)
BE774525 uterus .b 793 to 1172 1 to 370       375/370
(101 %)
17 diff
(95.5 %id)
TI_1948218786   .b 807 to 1458 772 to 121       652/1244
(52 %)
4 diff
(99.7 %id)
AA233637 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 850 to 1273 1 to 424       424/424
(100 %)
2 diff
(99.6 %id)
AL541045 placenta .b 871 to 1691 822 to 1   fully sequenced,   822/822
(100 %)
19 diff
(97.7 %id)
FN138975 breast carcinoma .b 880 to 977 1 to 96       96/96
(100 %)
4 diff
(95.9 %id)
AW381442 head_neck .b 952 to 1561 608 to 3       606/608
(99 %)
0 diff
(100 %id)
BX369387 Placenta Cot 25-normalized .b 962 to 1401 1 to 440       440/446
(98 %)
18 diff
(96.0 %id)
BI048844 uterus .b 968 to 1290 12 to 332       321/334
(96 %)
7 diff
(98.0 %id)
BI048966 uterus .b 972 to 1147 34 to 209       176/209
(84 %)
8 diff
(96.2 %id)
BQ772889 Chondrosarcoma Cell line .b 973 to 1720 764 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 746/746
(100 %)
2 diff
(99.8 %id)
CA423905 cell lines, Chondrosarcoma .b 977 to 1724 765 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 747/747
(100 %)
1 diff
(99.9 %id)
CA411843 Chondrosarcoma Grade II, Left Pelvis .b 980 to 1724 763 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 745/745
(100 %)
1 diff
(99.9 %id)
CA426666 cell lines, Chondrosarcoma .b 982 to 1724 761 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 743/743
(100 %)
0 diff
(100 %id)
AV751313 Pituitary .b 985 to 1497 1 to 509       509/512
(99 %)
6 diff
(98.9 %id)
C05190 heart .b 993 to 1248 1 to 256       256/256
(100 %)
0 diff
(100 %id)
AI924840 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1007 to 1721 714 to 1       714/714
(100 %)
12 diff
(98.4 %id)
AW118825 pooled .b 1029 to 1723 691 to 1       691/691
(100 %)
8 diff
(98.9 %id)
AI582268 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 1058 to 1726 669 to 4       666/669
(99 %)
10 diff
(98.6 %id)
AW593610 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1082 to 1725 644 to 1       644/644
(100 %)
7 diff
(99.0 %id)
CA415309 Chondrosarcoma Grade II, Left Pelvis .b 1086 to 1724 658 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 640/640
(100 %)
1 diff
(99.9 %id)
AI686918 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 1109 to 1721 613 to 1       613/613
(100 %)
4 diff
(99.4 %id)
AI689468 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1115 to 1726 613 to 1       613/613
(100 %)
8 diff
(98.7 %id)
AI565967 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 1163 to 1726 565 to 4       562/565
(99 %)
4 diff
(99.3 %id)
FN146872 breast carcinoma .b 1166 to 1240 1 to 75       75/76
(98 %)
4 diff
(94.8 %id)
AA975121 leiomyosarcoma, soft tissue .b 1182 to 1726 543 to 1   tiling clone,   543/543
(100 %)
6 diff
(98.9 %id)
AI471821 follicular lymphoma, lymph node .b 1202 to 1723 544 to 23   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 522/522
(100 %)
3 diff
(99.5 %id)
AI560103 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1202 to 1726 528 to 4       525/528
(99 %)
7 diff
(98.7 %id)
BF908806 uterus_tumor .b 1215 to 1595 401 to 25     Submitted on the opposite strand 377/401
(94 %)
0 diff
(100 %id)
DB380479 placenta .b 1235 to 1711 477 to 1       477/506
(94 %)
4 diff
(99.3 %id)
AI351758 pooled germ cell tumors .b 1236 to 1726 492 to 2       491/496
(98 %)
0 diff
(100 %id)
AW192267 adenocarcinoma, Pancreas .b 1236 to 1721 489 to 4       486/496
(97 %)
1 diff
(99.8 %id)
DB377458 placenta .b 1236 to 1720 485 to 1       485/522
(92 %)
6 diff
(98.9 %id)
BU675262 lung, Primary Lung Epithelial Cells .b 1236 to 1720 503 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 485/485
(100 %)
4 diff
(99.2 %id)
AA948069 pooled .b 1238 to 1715 479 to 2       478/479
(99 %)
0 diff
(100 %id)
AI457929 pooled .b 1238 to 1715 479 to 2       478/479
(99 %)
0 diff
(100 %id)
AI160736 brain, glioblastoma (pooled) .b 1241 to 1720 485 to 6       480/485
(98 %)
0 diff
(100 %id)
AA775662 heart .b 1243 to 1719 478 to 2       477/483
(98 %)
1 diff
(99.8 %id)
TI_1065986863   .b 1243 to 2205 10 to 982   tiling clone,   973/1224
(79 %)
40 diff
(96.8 %id)
AI347454 2 pooled tumors (clear cell type), Kidney .b 1249 to 1726 478 to 1       478/478
(100 %)
1 diff
(99.8 %id)
AI086345 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1289 to 1712 424 to 1       424/424
(100 %)
0 diff
(100 %id)
AI805695 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1292 to 1720 428 to 1       428/428
(100 %)
3 diff
(99.3 %id)
AW132052 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 1292 to 1715 427 to 3       425/427
(99 %)
4 diff
(99.1 %id)
AA441899   .b 1298 to 1720 424 to 1       424/424
(100 %)
6 diff
(98.6 %id)
CB143712 Liver .b 1321 to 1720 446 to 47   AAA Submitted on the opposite strand 400/400
(100 %)
0 diff
(100 %id)
AA233648 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1325 to 1724 401 to 1       401/401
(100 %)
2 diff
(99.6 %id)
AI470694 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1331 to 1726 395 to 1       395/395
(100 %)
3 diff
(99.3 %id)
DW009739 pooled .b 1339 to 1904 1 to 566   tiling clone,   566/566
(100 %)
8 diff
(98.6 %id)
AW204634   .b 1356 to 1724 386 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 369/369
(100 %)
0 diff
(100 %id)
AA618268 thyroid .b 1369 to 1456 1 to 88       88/88
(100 %)
2 diff
(97.8 %id)
AI696369 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 1411 to 1721 310 to 1       310/438
(70 %)
7 diff
(98.5 %id)
BE185256 head_neck .b 1426 to 1725 15 to 314       300/330
(90 %)
10 diff
(97.0 %id)
AI332311 lung .b 1438 to 1724 299 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 287/287
(100 %)
7 diff
(97.6 %id)
DB312658 thalamus .b 1445 to 1724 283 to 1       283/283
(100 %)
4 diff
(98.6 %id)
AI358603 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1445 to 1725 281 to 1       281/281
(100 %)
0 diff
(100 %id)
AI682854 adenocarcinoma, Pancreas .b 1453 to 1724 297 to 26   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 272/272
(100 %)
4 diff
(98.6 %id)
FN160150 breast carcinoma .b 1466 to 1580 1 to 117       117/117
(100 %)
2 diff
(98.3 %id)
DR422763 eye, Pterygium .b 1476 to 1721 1 to 246   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 246/246
(100 %)
1 diff
(99.6 %id)
AI383588   .b 1507 to 1720 215 to 1       215/215
(100 %)
2 diff
(99.1 %id)
FN066410 breast carcinoma .b 1513 to 1600 85 to 1     Submitted on the opposite strand 85/85
(100 %)
3 diff
(96.5 %id)
AI559765 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1533 to 1693 161 to 1       161/162
(99 %)
2 diff
(98.8 %id)
BM769969 stomach .b 1605 to 1724 1 to 120   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 120/120
(100 %)
0 diff
(100 %id)
BM818280 stomach .b 1605 to 1724 1 to 120   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 120/120
(100 %)
0 diff
(100 %id)
DC300799 bladder .c 1 to 566 1 to 566   tiling clone,   566/566
(100 %)
1 diff
(99.9 %id)
FN150889 breast carcinoma .c 255 to 344 89 to 1     Submitted on the opposite strand 89/99
(89 %)
0 diff
(100 %id)
AK302527 testis .c 402 to 1951 1 to 1550 S172P E259G     1550/1550
(100 %)
4 diff
(99.8 %id)
AK316476 thymus .c 405 to 2002 1 to 1598 exact tiling clone,   1598/1598
(100 %)
0 diff
(100 %id)
BX476503   .d 1 to 533 1 to 533   tiling clone,   533/533
(100 %)
1 diff
(99.9 %id)
DA413462 thalamus .d 343 to 869 2 to 528   tiling clone, capped   527/527
(100 %)
0 diff
(100 %id)
DA347028 substantia nigra .d 750 to 1298 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
BI918775 brain .d 1247 to 2008 1 to 758   tiling clone,   758/758
(100 %)
8 diff
(99.0 %id)
TI_57241181   .d 1247 to 2008 1 to 758       758/758
(100 %)
8 diff
(99.0 %id)
BQ775060 Bone, Human Chondrosarcoma Cell Line .d 1988 to 2476 507 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 489/489
(100 %)
0 diff
(100 %id)
DB310263 substantia nigra .d 2203 to 2478 277 to 1   tiling clone,   277/277
(100 %)
1 diff
(99.7 %id)
AL832618 human spinal cord .e 1 to 4736 1 to 4736 I83T I176M tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (18/19 A in genome downstream of last aligned base) 4736/4736
(100 %)
13 diff
(99.8 %id)
DA858190 placenta .e 598 to 1164 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
BF835367 head_neck .e 1032 to 1396 1 to 366   tiling clone,   366/366
(100 %)
10 diff
(97.3 %id)
DA376103 thalamus .e 1341 to 1892 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB158935 thymus .e 1572 to 2126 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA114463 cerebellum .e 1813 to 2368 2 to 557   tiling clone, capped   556/556
(100 %)
1 diff
(99.9 %id)
DA948427 Spleen .e 2122 to 2697 2 to 578   tiling clone, capped   577/577
(100 %)
3 diff
(99.5 %id)
DA336155 hippocampus .e 2186 to 2769 2 to 585   tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
DA280087 corpus callosum .e 2391 to 2962 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA040885 bladder .e 2446 to 3025 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DB311162 thalamus .e 4216 to 4737 525 to 1   tiling clone,   525/525
(100 %)
3 diff
(99.5 %id)
DB328949 placenta .e 4221 to 4737 531 to 1       531/531
(100 %)
9 diff
(98.4 %id)
AL589497 human spinal cord .f 1 to 361 29 to 389   tiling clone,   361/389
(92 %)
6 diff
(98.5 %id)
H92267 pineal gland .f 8 to 350 1 to 344       344/355
(96 %)
5 diff
(98.6 %id)
BE568885 bladder, carcinoma, cell line .f 43 to 579 1 to 534       534/607
(87 %)
13 diff
(97.9 %id)
AK316278 brain .f 44 to 1573 1 to 1530   tiling clone,   1530/1530
(100 %)
3 diff
(99.9 %id)
DC340114 thalamus .f 44 to 675 1 to 632       632/632
(100 %)
0 diff
(100 %id)
DC340245 thalamus .f 44 to 603 1 to 562       560/562
(99 %)
2 diff
(99.7 %id)
DC377173 brain .f 44 to 601 1 to 558       558/560
(99 %)
1 diff
(99.9 %id)
DC423653 uterus .f 44 to 618 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
AV754714 pituitary tumor .f 50 to 587 1 to 547       547/623
(87 %)
15 diff
(97.6 %id)
BE894575 melanotic melanoma, skin .f 61 to 708 1 to 648   tiling clone,   648/648
(100 %)
3 diff
(99.6 %id)
BI918778 brain .f 62 to 781 1 to 718       718/720
(99 %)
12 diff
(98.4 %id)
TI_57241184   .f 62 to 781 1 to 718       718/720
(99 %)
12 diff
(98.4 %id)
BF030057 hypernephroma, Kidney .f 63 to 700 1 to 636       636/638
(99 %)
7 diff
(99.0 %id)
AV658127 corresponding non cancerous liver tissue .f 65 to 723 1 to 658     Submitted on the opposite strand 658/658
(100 %)
31 diff
(95.3 %id)
DC390321 Spleen .g 1 to 564 1 to 564   tiling clone,   564/564
(100 %)
0 diff
(100 %id)
DC391067 Spleen .g 52 to 601 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DC338997 subthalamic nucleus .g 61 to 623 1 to 563       563/563
(100 %)
5 diff
(99.2 %id)
AK316232   .g 64 to 1440 1 to 1377 exact tiling clone,   1377/1377
(100 %)
0 diff
(100 %id)
DC367996   .g 64 to 592 1 to 529       529/529
(100 %)
0 diff
(100 %id)
DC358198 lung .g 66 to 561 1 to 496       496/496
(100 %)
3 diff
(99.4 %id)
BP308790 brain .g 66 to 664 1 to 598       598/598
(100 %)
4 diff
(99.4 %id)
DC356538 heart .g 67 to 629 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BP331997 renal proximal tubule .g 68 to 654 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
AA034349 uterus .g 85 to 505 8 to 433       426/433
(98 %)
13 diff
(97.0 %id)
BU943121 mixed (pool of 40 RNAs) .g 86 to 854 1 to 775       775/777
(99 %)
11 diff
(98.6 %id)
AA366956 Pancreas .g 88 to 408 1 to 322       322/326
(98 %)
2 diff
(99.4 %id)
BU162371 leiomyosarcoma, uterus .g 105 to 977 24 to 901       878/901
(97 %)
16 diff
(98.3 %id)
AA303544 aorta .g 115 to 285 1 to 171       171/171
(100 %)
0 diff
(100 %id)
T75096 whole brain .g 133 to 573 1 to 445       445/445
(100 %)
8 diff
(98.3 %id)
BE887626 leiomyosarcoma, uterus .g 141 to 774 1 to 633       633/633
(100 %)
3 diff
(99.6 %id)
AA033845 uterus .g 1154 to 1646 493 to 1   tiling clone,   493/493
(100 %)
3 diff
(99.4 %id)
R38530 whole brain .g 1345 to 1655 313 to 1   tiling clone,   313/481
(65 %)
3 diff
(99.4 %id)
BP193702 brain .h 1 to 581 1 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
DA560029 heart .h 11 to 390 194 to 573   capped   380/572
(66 %)
6 diff
(99.0 %id)
CN300449 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 61 to 599 1 to 539   tiling clone,   539/539
(100 %)
3 diff
(99.5 %id)
BE065574 breast .h 423 to 918 548 to 44   tiling clone, Submitted on the opposite strand 505/548
(92 %)
13 diff
(97.7 %id)
DA645156   .i 1 to 591 2 to 592   tiling clone, capped   591/591
(100 %)
2 diff
(99.7 %id)
DA944268 Spleen .i 2 to 570 2 to 570   tiling clone, capped   569/569
(100 %)
4 diff
(99.3 %id)
BG191245   .i 96 to 976 525 to 21   tiling clone, Submitted on the opposite strand 505/953
(52 %)
18 diff
(98.2 %id)
DA371740 thalamus .j 1 to 553 2 to 554   tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
BG186238   .j 252 to 1135 57 to 937 F122X L202F V206S K210S S211P ... tiling clone,   881/937
(94 %)
33 diff
(96.5 %id)
BG201652   .j 331 to 1160 833 to 9     Submitted on the opposite strand 825/836
(98 %)
27 diff
(96.8 %id)
AA243416 germinal center B cell .j 760 to 1179 439 to 20   tiling clone, AAA   420/420
(100 %)
0 diff
(100 %id)
CB151546 cervix, Uterine .k 1 to 686 1 to 686   tiling clone,   686/686
(100 %)
0 diff
(100 %id)
DA838194 placenta .k 2 to 559 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
AW381398 head_neck .k 444 to 986 544 to 8   tiling clone,   537/544
(98 %)
0 diff
(100 %id)
AW381443 head_neck .k 444 to 998 553 to 1   tiling clone,   553/553
(100 %)
4 diff
(99.3 %id)
AW381420 head_neck .k 754 to 1002 1 to 248   tiling clone,   248/248
(100 %)
1 diff
(99.6 %id)
BX424932 placenta .l 1 to 1116 1 to 1103 Y108X E157X K159X tiling clone,   1103/1103
(100 %)
18 diff
(98.4 %id)
AW276955 ovary, papillary serous ovarian metastasis .m 16 to 439 43 to 466   tiling clone, Submitted on the opposite strand 424/466
(90 %)
6 diff
(98.8 %id)
BU933794 mixed (pool of 40 RNAs) .m 434 to 1055 128 to 753   tiling clone, Suspected internal deletion 753/754
(99 %)
28 diff
(96.3 %id)
BG193854   .m 815 to 1423 1 to 607   tiling clone,   607/758
(80 %)
18 diff
(97.7 %id)
CA420880 Bone, Enchondroma cell line .n 1 to 708 20 to 726 A4T K213Q   Submitted on the opposite strand 708/709
(99 %)
4 diff
(99.5 %id)
CA420817 Bone, Enchondroma cell line .n 1 to 760 20 to 778 K213X tiling clone, Submitted on the opposite strand 760/760
(100 %)
3 diff
(99.7 %id)
AA361953   .n 16 to 351 1 to 338       338/338
(100 %)
4 diff
(98.9 %id)
AA360808   .n 18 to 304 1 to 289       289/299
(96 %)
6 diff
(98.0 %id)
AL576789 placenta, Placenta Cot 25-normalized .n 137 to 1083 947 to 1   tiling clone,   947/947
(100 %)
14 diff
(98.6 %id)
AK303187 thymus .o 1 to 1202 1 to 1202 exact tiling clone,   1202/1202
(100 %)
1 diff
(100.0 %id)
DC406265 thymus .o 1 to 487 1 to 487       487/487
(100 %)
1 diff
(99.8 %id)
BE766241 nervous_tumor .o 21 to 404 396 to 13       384/396
(96 %)
0 diff
(100 %id)
BE766243 nervous_tumor .o 21 to 404 395 to 12       384/395
(97 %)
0 diff
(100 %id)
BE766310 nervous_tumor .o 21 to 404 398 to 15       384/398
(96 %)
0 diff
(100 %id)
DC428869   .o 21 to 612 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
DT216101 brain .o 23 to 662 1 to 639   tiling clone,   639/639
(100 %)
2 diff
(99.7 %id)
R06012 liver and spleen .o 30 to 418 1 to 396       396/409
(96 %)
11 diff
(97.4 %id)
R05917 liver and spleen .o 1103 to 1265 172 to 10   tiling clone,   163/172
(94 %)
0 diff
(100 %id)
AA304488 aorta .p 1 to 363 1 to 366   tiling clone,   366/366
(100 %)
3 diff
(99.2 %id)
AW954801   .p 2 to 634 1 to 630 M29V D31Y I140F Y146M A147L ... tiling clone,   630/630
(100 %)
19 diff
(97.0 %id)
BX426159 thymus .q 1 to 791 1 to 791   tiling clone,   791/804
(98 %)
24 diff
(97.1 %id)
BQ893788 dorsal root ganglia .q 655 to 1582 1 to 928 I60T tiling clone,   928/928
(100 %)
5 diff
(99.5 %id)
DT216232 brain .r 1 to 593 1 to 593   tiling clone,   593/593
(100 %)
0 diff
(100 %id)
AW167093 serous papillary carcinoma, high grade, 2pooled tumors, uterus .r 450 to 1108 661 to 3       659/664
(99 %)
2 diff
(99.7 %id)
AW438815 serous papillary carcinoma, high grade, 2pooled tumors, uterus .r 450 to 1098 648 to 1       648/674
(96 %)
10 diff
(98.6 %id)
BP420083 small intestine .r 515 to 1017 1 to 503     Submitted on the opposite strand 503/503
(100 %)
0 diff
(100 %id)
BE221241 malignant melanoma, metastatic to lymphnode, skin .r 549 to 1111 574 to 12   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 563/566
(99 %)
1 diff
(99.9 %id)
AI204255 lung .r 620 to 1108 490 to 2       489/490
(99 %)
0 diff
(100 %id)
FN167037 breast carcinoma .r 681 to 771 1 to 91       91/91
(100 %)
4 diff
(95.7 %id)
FN081903 breast carcinoma .r 711 to 788 79 to 1     Submitted on the opposite strand 79/80
(98 %)
1 diff
(98.8 %id)
BE826206 lung_normal .s 1 to 616 1 to 615 P2S I6S K7N L8* tiling clone,   615/615
(100 %)
9 diff
(98.6 %id)
CA390015 eye, RPE/choroid .t 1 to 664 1 to 664 exact tiling clone,   664/664
(100 %)
0 diff
(100 %id)
BG661331 Islets of Langerhans, Pancreas .u 1 to 426 1 to 426 exact tiling clone,   426/426
(100 %)
0 diff
(100 %id)
CB150455 cervix, Uterine .va 1 to 710 1 to 709   tiling clone,   709/709
(100 %)
3 diff
(99.6 %id)
BQ437417 leiomyosarcoma, uterus .va 200 to 1061 1 to 862       862/866
(99 %)
5 diff
(99.5 %id)
AA302905 adipose tissue, white .va 382 to 678 1 to 297       297/297
(100 %)
1 diff
(99.7 %id)
AB116553 brain (temporal lobe) .va 383 to 1561 1 to 1179   tiling clone, AAA   1179/1179
(100 %)
2 diff
(99.9 %id)
ES316329 pool of melanoma cell lines .va 397 to 910 580 to 67     Submitted on the opposite strand 514/580
(88 %)
0 diff
(100 %id)
AA495793 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .va 466 to 951 5 to 491     Submitted on the opposite strand 487/491
(99 %)
9 diff
(98.2 %id)
AA149783 colon, tumor .va 507 to 959 1 to 458       458/462
(99 %)
6 diff
(98.8 %id)
CB052790 leiomyosarcoma, soft tissue .va 657 to 1169 3 to 515   fully sequenced,   513/515
(99 %)
6 diff
(98.9 %id)
CB151474 cervix, Uterine .va 718 to 1302 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
R13843 whole brain .va 866 to 1341 1 to 477   tiling clone,   477/479
(99 %)
10 diff
(98.0 %id)
H11562 whole brain .va 895 to 1347 1 to 460       460/463
(99 %)
12 diff
(97.5 %id)
BI060366 uterus_tumor .va 1000 to 1157 160 to 3       158/169
(93 %)
0 diff
(100 %id)
AW022459 cochlea, ear .va 1102 to 1456 8 to 362       355/362
(98 %)
6 diff
(98.4 %id)
AA495729 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .va 1119 to 1558 440 to 1     Submitted on the opposite strand 440/440
(100 %)
1 diff
(99.8 %id)
FN052710 breast carcinoma .va 1137 to 1202 1 to 66       66/67
(98 %)
1 diff
(98.6 %id)
FN064223 breast carcinoma .va 1137 to 1202 1 to 68       68/69
(98 %)
3 diff
(95.7 %id)
CB052789 leiomyosarcoma, soft tissue .va 1139 to 1558 440 to 22   fully sequenced, AAA   419/419
(100 %)
3 diff
(99.3 %id)
AI160386 uterus .va 1149 to 1562 415 to 2   tiling clone,   414/416
(99 %)
0 diff
(100 %id)
AA151775 colon, tumor .va 1175 to 1533 359 to 1       359/359
(100 %)
0 diff
(100 %id)
BX109086 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .va 1180 to 1558 1 to 379   AAA   379/379
(100 %)
0 diff
(100 %id)
AA418639 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .va 1180 to 1559 1 to 380       380/380
(100 %)
0 diff
(100 %id)
AI263905 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .va 1213 to 1558 346 to 1       346/346
(100 %)
2 diff
(99.5 %id)
AA302904 adipose tissue, white .va 1230 to 1558 331 to 1       331/332
(99 %)
7 diff
(97.9 %id)
BF526295 brain, glioblastoma with EGFR amplification .va 1242 to 1983 1 to 726       726/726
(100 %)
28 diff
(96.2 %id)
AI590796 ovary, tumor, 5 pooled (see description) .va 1282 to 1558 277 to 1       277/277
(100 %)
1 diff
(99.7 %id)
BX476359   .va 1469 to 1955 1 to 487   tiling clone,   487/487
(100 %)
0 diff
(100 %id)
BI013497 lung_tumor .va 1661 to 2004 346 to 3       344/346
(99 %)
0 diff
(100 %id)
AI336854 pooled germ cell tumors .va 1866 to 2356 494 to 4   tiling clone,   491/494
(99 %)
0 diff
(100 %id)
R36988 whole brain .va 1958 to 2356 416 to 8       409/419
(97 %)
0 diff
(100 %id)
H11453 whole brain .va 1968 to 2354 406 to 11   AAA   396/407
(97 %)
10 diff
(97.6 %id)
AW015958   .va 1982 to 2354 390 to 18   AAA   373/381
(97 %)
1 diff
(99.8 %id)
DB071265 testis .va 2027 to 2568 2 to 546   tiling clone, to resequence, capped   545/545
(100 %)
4 diff
(99.3 %id)
AI910770 colon, colon tumor, RER+ .va 2133 to 2563 431 to 1       431/433
(99 %)
6 diff
(98.7 %id)
AI910777 colon, colon tumor, RER+ .va 2173 to 2564 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
FN095413 breast carcinoma .va 2380 to 2488 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
DB340199 testis .va 3267 to 3822 556 to 1 exact tiling clone, to resequence,   556/556
(100 %)
1 diff
(99.9 %id)
DA671758   .vb-u 1 to 573 2 to 575 exact tiling clone, capped   574/574
(100 %)
3 diff
(99.5 %id)
DA810608 brain .vb-u 199 to 744 2 to 547 exact tiling clone, capped   546/546
(100 %)
0 diff
(100 %id)
BX952425   .vb-u 412 to 1063 1 to 652   tiling clone,   652/653
(99 %)
3 diff
(99.6 %id)
DB150896 thymus .vb-u 593 to 1177 2 to 586   tiling clone, capped   585/585
(100 %)
3 diff
(99.5 %id)
BX537508 human small intestine .vb-u 786 to 3766 59 to 3039   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2981/3021
(98 %)
6 diff
(99.9 %id)
DA931957 Spleen .vb-u 1072 to 1621 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA144697 amygdala .vb-u 1089 to 1638 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB184823 liver, tumor tissue .vb-u 1089 to 1656 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BX477235   .vb-u 1148 to 1665 1 to 518       518/518
(100 %)
1 diff
(99.9 %id)
DA141750 alzheimer cortex .vb-u 1157 to 1709 2 to 554   tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
AW663261 2 pooled high-grade transitional celltumors, genitourinary tract .vb-u 1191 to 1528 22 to 362       341/363
(93 %)
7 diff
(98.1 %id)
DA384104 thalamus .vb-u 1196 to 1763 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BX645196   .vb-u 1327 to 1807 1 to 481       481/481
(100 %)
0 diff
(100 %id)
AV756487 bone marrow .vb-u 1387 to 1857 84 to 548       465/550
(84 %)
4 diff
(99.3 %id)
DA945926 Spleen .vb-u 1555 to 2127 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
FN119723 breast carcinoma .vb-u 1675 to 1772 98 to 1     Submitted on the opposite strand 98/101
(97 %)
0 diff
(100 %id)
AA385841 Pancreas .vb-u 1706 to 2019 1 to 316       316/317
(99 %)
3 diff
(99.1 %id)
DA608668   .vb-u 2080 to 2612 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
BF089011 head_neck .vb-u 2174 to 2508 333 to 1       333/333
(100 %)
12 diff
(96.4 %id)
N44956 melanocyte .vb-u 2251 to 2588 1 to 342       342/345
(99 %)
12 diff
(96.6 %id)
BM987655 mixed .vb-u 2269 to 2755 1 to 487     Submitted on the opposite strand 487/487
(100 %)
4 diff
(99.2 %id)
AA404636 ovarian tumor, ovary .vb-u 2278 to 2759 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
AA180763 muscle, skeletal muscle .vb-u 2399 to 3007 1 to 602       602/607
(99 %)
18 diff
(97.1 %id)
BG676811 skin, squamous cell carcinoma .vb-u 2482 to 3256 1 to 778       778/778
(100 %)
24 diff
(97.0 %id)
AW993106 breast_normal .vb-u 2485 to 2813 1 to 329       329/657
(50 %)
4 diff
(99.4 %id)
BE182155 head_neck .vb-u 2671 to 2933 274 to 12     Submitted on the opposite strand 263/274
(95 %)
0 diff
(100 %id)
BF375154 stomach .vb-u 2788 to 3255 470 to 1       470/489
(96 %)
25 diff
(94.9 %id)
AA480136 ovarian tumor, ovary .vb-u 2926 to 3438 1 to 513       513/513
(100 %)
0 diff
(100 %id)
AA476356   .vb-u 2934 to 3363 1 to 430     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 430/430
(100 %)
0 diff
(100 %id)
BF831275 head_neck .vb-u 2943 to 3238 337 to 41     Submitted on the opposite strand 297/337
(88 %)
0 diff
(100 %id)
FN063684 breast carcinoma .vb-u 3049 to 3147 1 to 100       100/104
(96 %)
2 diff
(98.1 %id)
N90350 multiple sclerosis lesions .vb-u 3097 to 3699 1 to 594       594/639
(92 %)
17 diff
(97.4 %id)
AA032029 uterus .vb-u 3199 to 3403 1 to 211   fully sequenced,   211/211
(100 %)
1 diff
(99.6 %id)
DB346119 thymus .vb-u 3225 to 3766 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
DB332541 Spleen .vb-u 3244 to 3772 529 to 1   tiling clone,   529/529
(100 %)
0 diff
(100 %id)
BE049439 adenocarcinoma, Pancreas .vb-u 3246 to 3755 510 to 1       510/510
(100 %)
0 diff
(100 %id)
N33172 melanocyte .vb-u 3294 to 3753 462 to 1       462/462
(100 %)
4 diff
(99.2 %id)
AI275105 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vb-u 3311 to 3761 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AW130518 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .vb-u 3317 to 3763 452 to 6       447/452
(98 %)
0 diff
(100 %id)
AI290106 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vb-u 3325 to 3760 436 to 1       436/436
(100 %)
0 diff
(100 %id)
AW613660 2 pooled high-grade transitional celltumors, genitourinary tract .vb-u 3339 to 3753 415 to 1       415/415
(100 %)
1 diff
(99.8 %id)
N90723 lung .vb-u 3343 to 3759 414 to 1       414/507
(81 %)
8 diff
(98.5 %id)
AA031928 uterus .vb-u 3373 to 3753 383 to 1   fully sequenced,   383/383
(100 %)
2 diff
(99.5 %id)
AW028857 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .vb-u 3416 to 3761 351 to 6       346/351
(98 %)
0 diff
(100 %id)
AI061108   .vb-u 3423 to 3766 374 to 31   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 344/344
(100 %)
13 diff
(96.3 %id)
AI472619 pooled .vb-u 3444 to 3661 218 to 1       218/218
(100 %)
0 diff
(100 %id)
AA476308   .vb-u 3486 to 3763 293 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 278/278
(100 %)
0 diff
(100 %id)
AA182891 muscle, skeletal muscle .vb-u 3561 to 3709 149 to 1       149/151
(98 %)
0 diff
(100 %id)
DA192474 amygdala .vc 1 to 602 2 to 604   tiling clone, to resequence, capped   603/603
(100 %)
1 diff
(99.9 %id)
BG573645 placenta .vc 595 to 1152 1 to 579   tiling clone,   579/776
(74 %)
62 diff
(92.1 %id)
BX955239   .vc 756 to 1426 1 to 670 exact tiling clone,   670/670
(100 %)
3 diff
(99.6 %id)
AU185020 skin .vc 1203 to 1616 414 to 1   tiling clone,   414/414
(100 %)
0 diff
(100 %id)
DB303422 amygdala .vc 2265 to 2811 548 to 1   tiling clone, to resequence,   548/548
(100 %)
1 diff
(99.9 %id)
DC413395 lung, tumor tissue .vd 1 to 547 1 to 547   tiling clone,   547/547
(100 %)
1 diff
(99.9 %id)
F12860 brain, total brain .vd 36 to 350 1 to 315       315/315
(100 %)
0 diff
(100 %id)
BM927291 brain .vd 61 to 1079 1 to 1023 K25X V67G E100K L114F tiling clone,   1023/1044
(97 %)
43 diff
(95.9 %id)
F10462 brain, total brain .vd 1186 to 1512 327 to 1   tiling clone,   327/327
(100 %)
0 diff
(100 %id)
BX426042 thymus .ve-u 1 to 984 1 to 981 V9R F10I F11L W12L W13G ... tiling clone,   981/981
(100 %)
26 diff
(97.4 %id)
BX456531 thymus .ve-u 1 to 703 1 to 699   tiling clone,   699/727
(96 %)
10 diff
(98.7 %id)
DA671945   .vf 1 to 590 2 to 591 exact tiling clone, capped   590/590
(100 %)
0 diff
(100 %id)
TI_149272705   .vg 1 to 579 687 to 109 D6A tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 579/941
(61 %)
9 diff
(99.1 %id)
BQ774444 Chondrosarcoma Grade II, Left Pelvis .vg 9 to 583 593 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 575/575
(100 %)
2 diff
(99.7 %id)
AI682015 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vh-u 1 to 508 526 to 19 exact tiling clone, AAA   508/508
(100 %)
0 diff
(100 %id)
BX105908 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vh-u 87 to 508 436 to 15   AAA   422/422
(100 %)
1 diff
(99.8 %id)
AI682006 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vh-u 93 to 508 434 to 19   AAA   416/416
(100 %)
2 diff
(99.6 %id)
AW129690 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vi-u 1 to 430 433 to 2 exact tiling clone,   432/433
(99 %)
0 diff
(100 %id)
AV701746 adrenal gland Gene IFI44L, variant not shown         Suspected internal deletion, this clone was ignored    
AK293385 bladder Gene IFI44L, variant not shown         Suspected internal deletion, this clone was ignored    
AW837927 leiomios Gene IFI44L, variant not shown              
AW838065 leiomios Gene IFI44L, variant not shown              
BF916498 uterus_tumor Gene IFI44L, variant not shown              
BF924146 nervous_tumor Gene IFI44L, variant not shown              
BF990024 placenta_normal Gene IFI44L, variant not shown              
BI059949 uterus_tumor Gene IFI44L, variant not shown              
DA039375 bladder Gene IFI44L, variant not shown       capped      
DC301119 bladder Gene IFI44L, variant not shown         Suspected internal deletion, this clone was ignored    
DA046271 bladder Gene IFI44L, variant not shown       capped      
DB304514 brain Gene IFI44L, variant not shown         This clone was ignored    
DA212818 brain Gene IFI44L, variant not shown       capped This clone was ignored    
DA372583 thalamus Gene IFI44L, variant not shown       capped      
DB311085 thalamus Gene IFI44L, variant not shown              
DA374682 thalamus Gene IFI44L, variant not shown       capped      
DA387953 thalamus Gene IFI44L, variant not shown       capped      
AL602810 human skeletal muscle Gene IFI44L, variant not shown         Suspected internal deletion, this clone was ignored    
BX956532   Gene IFI44L, variant not shown              
FN054770 breast carcinoma Gene IFI44L, variant not shown              
FN151067 breast carcinoma Gene IFI44L, variant not shown              
AV698466 hepatocellular carcinoma Gene IFI44L, variant not shown         Suspected internal deletion, this clone was ignored    
AV685599 hepatocellular carcinoma Gene IFI44L, variant not shown         Suspected internal deletion, this clone was ignored    
AV688913 hepatocellular carcinoma Gene IFI44L, variant not shown         Suspected internal deletion, this clone was ignored    
AV654694 corresponding non cancerous liver tissue Gene IFI44L, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV722623 hypothalamus Gene IFI44L, variant not shown         This clone was ignored    
AV729203 hypothalamus Gene IFI44L, variant not shown         Suspected internal deletion, this clone was ignored    
H70440 liver and spleen Gene IFI44L, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
H70441 liver and spleen Gene IFI44L, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
W06927 lung Gene IFI44L, variant not shown         Suspected internal deletion, this clone was ignored    
AA464178 ovarian tumor, ovary Gene IFI44L, variant not shown         This clone was ignored    
AA464768 ovarian tumor, ovary Gene IFI44L, variant not shown         This clone was ignored    
AI684185 serous papillary carcinoma, high grade, 2pooled tumors, uterus Gene IFI44L, variant not shown              
DA934088 Spleen Gene IFI44L, variant not shown       capped      
DA940906 Spleen Gene IFI44L, variant not shown       capped      
DB333179 Spleen Gene IFI44L, variant not shown              
DB156919 thymus Gene IFI44L, variant not shown       capped      
DB160931 thymus Gene IFI44L, variant not shown       capped      
DB232325 trachea Gene IFI44L, variant not shown       capped This clone was ignored    
DB350079 trachea Gene IFI44L, variant not shown         This clone was ignored    
CA432278 cell lines, Enchondroma Gene IFI44L, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb-u, .vc, .vd, .ve-u, .vf, .vg, .vh-u, .vi-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C